Samsung Biologics achieved a record-breaking earnings performance in the first quarter of 2024, reporting the highest-ever quarterly revenue and operating profit, thanks to increased production from Plant 4 and the expansion of its biosimilar business.The biopharmaceutical company reported a consoli
Biotech startups supported by Celltrion through its “open innovation strategy” are nesting in Seoul Biohub.Celltrion said Thursday that it attended the Seoul Biohub Global Center opening ceremony in Dongdaemun-gu, Seoul. Three companies supported by Celltrion—MediMabBio, S&K Therapeutics, and Entero
In 5 to 10 percent of patients who receive radiation therapy for prostate cancer, there is a side effect that can show up months to years later -- hemorrhagic cystitis. Why does this problem occur in the bladder after radiation treatment to kill cancer cells in the prostate?"The bladder is directly
LG Chem has announced a partnership with EuBiologics to enhance the domestic production capabilities of pediatric vaccines in Korea.The collaboration focuses on developing the hexavalent vaccine LR20062, which is designed to protect against six diseases -- diphtheria, tetanus, pertussis (whooping co
Novartis' angiotensin receptor-neprilysin inhibitor (ARNI) heart failure treatment Entresto (sacubitril/valsartan) has reduced hospitalization rates in patients with newly diagnosed (de novo) heart failure with mildly reduced ejection fraction (HFmrEF) and heart failure with preserved ejection fract
The agony of university hospital heads is deepening as medical professors who complained of “burnout” announced their resignation on Thursday following the shortened medical treatment.Many senior physicians have been exhausted from overwork since trainee doctors resigned about two months ago to prot
VUNO said its AI-based retinal imaging diagnostic support solution, VUNOMED Fundus AI, has received approval from the Ministry of Food and Drug Safety (MFDS) for an integrated review of innovative medical devices.This marks it as the first AI-powered ophthalmic device in the country to gain such rec
Ybrain said it has signed a memorandum of understanding (MOU) with Meditrix, a digital medical device company, to collaborate on developing a digital treatment device for depression and various other digital healthcare products.The core content of the MOU is the future launch and marketing cooperati
Noul, an AI-based blood and cancer diagnostic platform company, said it presented the results of a clinical performance study of its malaria diagnostic solution at an African conference.The results show that the solution has a sensitivity of up to 94.4 percent and a specificity of up to 98.1 percent
Moderna and the Korean National Institute for Bioprocessing Research and Training (K-NIBRT) at Yonsei University have signed an agreement to develop mRNA education content and programs, accelerating the full-scale operation of the curriculum.The agreement follows a memorandum of understanding signed
Medical AI company Lunit said Thursday that it would present seven research studies using its AI biomarker platform, “Lunit SCOPE,” at the 2024 American Society of Clinical Oncology (ASCO 2024) in Chicago, U.S., from May 31 to June 4.Lunit will present a poster on identifying HER2 Ultra-Low breast c
Macrogen, a Korean digital healthcare company, said it held a groundbreaking ceremony for the Songdo Global Genome Center in Incheon. The company emphasizes that this facility is Asia's largest genomic big data hub in terms of data quantity. The construction, slated for completion by the second half
Onconic Therapeutics, a subsidiary of Jeil Pharma Holdings, said it received approval from the Ministry of Food and Drug Safety for Jaqbo (ingredient: Zastaprazan), a drug for the treatment of gastroesophageal reflux disease (GERD) and Korea's 37th domestically developed new drug.Jaqbo represents a
Severance Hospital researchers have identified a promising method to rejuvenate the effectiveness of natural killer cells in combating multiple myeloma, a serious form of blood cancer.Multiple myeloma is characterized by the malignant transformation of plasma cells, which are crucial to the body's i
Daewoong Pharmaceutical said Thursday that Fexuclue's prescription sales grew 57 percent year over year to 17 billion won ($12.4 million) in the first quarter of this year.According to drug statistics and information UBIST, seven products in the second-generation PPI series recorded negative growth
The Research Investment for Global Health Technology Foundation, commonly known as the RIGHT Foundation, said it opened its grant application aimed at significantly enhancing health equity in infectious disease sectors within low- and middle-income countries. The foundation is focusing its funding o
VUNO will exhibit its AI-powered cardiac arrest risk monitoring device, VUNO Med-DeepCARS, at the 44th Korean Society of Critical Care Medicine (KSCCM) Annual Congress-Acute and Critical Care Congress 2024, which will be held from Thursday to Friday.The company plans to showcase the superiority and
Professor Bang Jae-seung, chairman of the emergency committee of the Seoul National University College of Medicine and Seoul National University Hospital (SNUH) faculty council, will lay down both the chairmanship and professorship.Bang and three other medical professors who served on the emergency
Viatris Korea celebrated 25 years of Lipitor (atorvastatin) sales in Korea, highlighting its pivotal role in dyslipidemia treatment and cardiovascular diseases (CVD) prevention at a press conference in Seoul on Wednesday.After its launch in 1997, Lipitor became the top-prescribed statin in Korea by
Chong Kun Dang said it has entered into a licensing agreement with Curigin, a local gene therapy developer, for the latter's CA102, a gene therapy candidate targeting superficial bladder cancer.Founded in 2016, Curigin has pioneered the development of siRNA technologies capable of suppressing multip